期刊文献+

血管紧张素转换酶抑制剂与血管紧张素Ⅱ受体拮抗剂联合应用对心肾的保护作用 被引量:5

下载PDF
导出
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2009年第6期570-574,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
  • 相关文献

参考文献41

  • 1Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med ,2008,264:224 - 236.
  • 2Elliott WJ. Therapeutic trials comparing angiotensin-converting enzyme inhlbitors and angiotensin Ⅱ receptor blockers. Curr Hypertens Rep,2000,2:402 - 411.
  • 3Lewis E J, Hunsicker LG, Clarke WR,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med,2001,345:851 -860.
  • 4Lewis EJ,Hunsicker LG, Bain RP, et al. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med, 1993,329:1456 -1462.
  • 5Yusuf S,Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med,2000,342 : 145 - 153.
  • 6Cohn JN, Tognoni G, for the Val-HeFT Investigators. Effects of the angiotensin receptor blocker valsartan on morbidity and mortality in heart failure: The Valsartan Heart Failure Trial (Val-HeFT). Circulation,2000,267:2672 - 2676.
  • 7Ferrario, CM. Role of angiotensin Ⅱ in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst ,2006,7:3 - 14.
  • 8BurnierM,Brumner HR. Angiotensin Ⅱ receptor antagonists. Lancet , 2000,355:637 - 645.
  • 9Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin Ⅱ receptor blockers to halt progression of chronic renal disease:pathophysiology and indications. Kidney Int,2005,67:799 -812.
  • 10Unger T,Stoppelhaar M. Rationale for double renin-angiotensin-aldosterone-system blockade. Am J Cardiol,2007 ,100 :25 J - 31J.

同被引文献70

  • 1郝丽.肾性高血压的发病机制及诊治进展[J].安徽医学,2005,26(1):3-4. 被引量:15
  • 2刘桂莲,于春梅.依那普利治疗高血压病100例疗效观察[J].吉林医学,2006,27(1):40-40. 被引量:5
  • 3张晓英.老年人肾性高血压的治疗[J].中华老年医学杂志,2006,25(2):154-156. 被引量:9
  • 4中华人民共和国卫生部心血管病研究中心.中国高血压防治指南(2009年修订版)[M].北京:人民卫生出版社,2009:85-8.
  • 5Nishikawa S, Tatsumi T, Shiraishi J, et al. Nicorandil regulates Bcl--2 family proteins and protects cardiac myocytes against hypoxia--induced apoptosis[J]. J Mol Cell Cardiol, 2006, 40(4): 510--519.
  • 6Pachl J, Duska F, Waldauf P, et al. Apoptosis as an early event in the development of multiple organ failure? [J]. Physiol Res, 2005, 586(3) : 697--699.
  • 7Das A, Xi L, Kukreja R C. Phosphodiesterase--5 inhibitor slidenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling[J]. J Biol Chem, 2005, 280(13) : 12944--12955.
  • 8zou Y P, Wu J L, Fan Q, et al. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment[J]. Clinical Science, 2006, 112 (5) :299--304.
  • 9Ling H, Lou Y. Total flavonea from Elsholtzia blanda reduce infarct size during acute myocardial ischemia by inhibiting myocardial apoptosis in rats[J]. J Ethnopharmacol, 2005, 101(3): 169--175.
  • 10Shirito K, Otani H, Yamamoto F, et aI. MK2-/-gene knockout mouse hearts carry anti--apoptotic signal and are resistant to ischemia reperfusion injury[J]. J Mol Cell Cardiaol, 2005,38 (1) : 93 -- 97.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部